[Progress in therapy for chronic heart failure].
Hori
Masatsugu
M
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000008:administration & dosage; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004070:Digitalis; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006801:Humans; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004232:Diuretics; D014665:Vasodilator Agents